India Paints Sector 2026: Asian Paints, Berger & Kansai
India's paints sector sits at an interesting juncture in 2026. The structural demand story — housing boom, premiumisation, Tier-2/3 expansion, and rising per-capita consumption — remains intact. But the past two years have tested the incumbents: crude-linked raw material cost cycles, a margin squeeze, and now the first genuine competitive disruption in decades from Birla Opus (launched late 2023) entering with aggressive pricing.
We pulled live fundamentals from the DocStoX dataset (sourced from NSE/BSE audited filings) for the three listed incumbents — Asian Paints, Berger Paints, and Kansai Nerolac — and compared them on the metrics that matter for a consumer-facing, high-ROCE business.
Sector Snapshot: Why Paints Are a Premium Business
Paints companies in India have historically earned outsized returns. Asian Paints, the undisputed leader, spent most of the 2010s at 30–40x earnings — a premium that reflected its near-monopoly distribution (60,000+ dealer network), brand moat, and reliably high return on capital.
The category economics are simple: paint is a low-ticket, repeat-purchase product (homes are repainted every 3–5 years), raw material cost (TiO₂, crude-linked solvents) is manageable at scale, and distribution depth creates a durable competitive moat. These characteristics drive structural ROCE in the 20–35% range for the top players — rare among listed Indian consumer businesses.
Key Metrics at a Glance (DocStoX Data, July 2026)
Here is how the three listed leaders stack up on the numbers that matter:
- Asian Paints (ASIANPAINT): Market Cap ₹2,56,445 Cr | P/E 59.3x | ROE 21.8% | ROCE 26.0% | EBITDA Margin 19.0% | PAT Margin 12.4% | D/E 0.18 | Div Yield 1.01% | Revenue ₹35,584 Cr | PAT ₹4,395 Cr
- Berger Paints (BERGEPAINT): Market Cap ₹57,983 Cr | P/E 51.5x | ROE 17.8% | ROCE 22.0% | EBITDA Margin 15.0% | PAT Margin 9.5% | D/E 0.09 | Div Yield 0.79% | Revenue ₹11,880 Cr | PAT ₹1,128 Cr
- Kansai Nerolac (KANSAINER): Market Cap ₹16,216 Cr | P/E 27.5x | ROE 8.8% | ROCE 12.0% | EBITDA Margin 12.0% | PAT Margin 7.2% | D/E 0.05 | Div Yield 1.2% | Revenue ₹8,052 Cr | PAT ₹576 Cr
Asian Paints: Still the ROCE King, but Paying a Premium
Asian Paints is the undisputed market leader — its revenue of ₹35,584 crore is nearly 3x Berger Paints and over 4x Kansai Nerolac, underlining how dominant its position is in Indian decorative paints. Its ROCE of 26% remains the highest in the sector, a reflection of strong asset turns and pricing power.
The EBITDA margin of 19% is the strongest in the peer group — Berger sits at 15% and Kansai at 12%. The margin gap reflects Asian Paints' scale advantage in raw material procurement, its higher share of premium products (royale, enamel, textures), and the operating leverage from its 60,000+ dealer distribution network.
The catch: you pay for all of it. At 59.3x earnings, Asian Paints is priced for near-perfection. The stock is currently trading at ₹2,673.8, a meaningful 10% below its 52-week high of ₹2,985.7. Its price-to-book ratio of 12.27x implies the market is willing to pay a steep premium for the quality of the franchise — but leaves little room for earnings disappointment.
Berger Paints: The Quality #2, Trading at a Relative Discount
Berger Paints has consistently been the most underrated of the three. With revenue of ₹11,880 crore, a PAT of ₹1,128 crore, and an ROCE of 22%, it runs a high-quality business — just at a slightly smaller scale than Asian Paints.
Berger's EBITDA margin of 15% trails Asian Paints by 4 percentage points, but the company has been on a multi-year journey to close the gap through product mix improvements and deeper penetration of interior emulsion (where margins are higher than industrial coatings). D/E of just 0.09 means it is almost entirely equity-funded — a conservative balance sheet that gives room to invest in capacity and branding without distress risk.
At 51.5x P/E, Berger is also not cheap in absolute terms. But relative to Asian Paints, the discount is meaningful — and arguably unjustified given how close the return-on-capital metrics are. Berger's 52-week range (₹391–₹594) suggests it is currently (₹497) in the lower half of the range, giving patient long-term investors a better entry point than the 52-week high would imply.
Kansai Nerolac: The Laggard, But Cheap for a Reason
Kansai Nerolac is the most interesting valuation story — and the most structurally challenged. Its P/E of 27.5x is less than half of Asian Paints, which on the surface looks attractive. But a closer look at the fundamentals explains the discount.
Kansai's ROE of just 8.8% and ROCE of 12% are well below the sector leaders. EBITDA margin at 12% means every rupee of revenue generates far less operating profit than peers. The culprit: Kansai has historically been more exposed to the industrial and automotive coatings segment (where OEM pricing pressure is high and margins thin) versus the higher-margin decorative segment that Asian Paints and Berger dominate.
Revenue of ₹8,052 crore is respectable in absolute terms, but PAT of only ₹576 crore on that revenue base illustrates the structural margin challenge. Kansai's Nippon Paint-linked parentage brings technology expertise in industrial coatings, but hasn't yet translated to a material decorative upsell story in India.
At 27.5x, Kansai is cheap — but the returns don't yet justify re-rating to Asian Paints levels. Watch for a consistent improvement in decorative mix and a sustained ROCE crossing 18–20% before treating this as a value buy.
The Birla Opus Wild Card
No paints sector analysis in 2026 is complete without addressing the elephant in the room: Birla Opus, the Aditya Birla Group's foray into paints (launched late 2023), is now a real competitive threat. With ₹10,000 crore committed capex, aggressive pricing 10–15% below Asian Paints on select SKUs, and deep distribution investment, it has already captured mid-single-digit market share in decorative paints within 18 months of launch.
The impact is visible in Asian Paints' recent volume numbers — decorative volume growth has moderated. For investors, this adds a new risk variable that was absent for most of the past decade: genuine new-entrant competition in a market that had been an effective duopoly (Asian Paints + Berger) in terms of brand pull and distribution reach.
Whether Birla Opus sustains the aggression (or whether Aditya Birla Group's payback period expectations force them to moderate pricing) will be the single biggest swing factor for sector margins over the next 2–3 years.
How the Three Compare: Quick Summary Table
| Metric | Asian Paints | Berger Paints | Kansai Nerolac |
| Market Cap | ₹2,56,445 Cr | ₹57,983 Cr | ₹16,216 Cr |
| Revenue | ₹35,584 Cr | ₹11,880 Cr | ₹8,052 Cr |
| PAT | ₹4,395 Cr | ₹1,128 Cr | ₹576 Cr |
| EBITDA Margin | 19% | 15% | 12% |
| ROCE | 26% | 22% | 12% |
| ROE | 21.8% | 17.8% | 8.8% |
| P/E | 59.3x | 51.5x | 27.5x |
| D/E | 0.18 | 0.09 | 0.05 |
| Div Yield | 1.01% | 0.79% | 1.2% |
The DocStoX Take
For quality-focused investors, the paints sector in 2026 offers a trade-off between paying up for Asian Paints' franchise (and hoping the Birla Opus disruption moderates) or finding relative value in Berger Paints — which runs nearly as strong a business at a meaningful P/E discount to the leader.
Kansai Nerolac looks cheap on headline multiples, but the sub-13% ROCE suggests the business fundamentals don't yet justify a premium re-rating. It belongs in the "watch and wait" bucket until decorative mix improves structurally.
All three companies are virtually debt-free — in a rising interest rate environment, that's a genuine structural advantage. The sector's long-term tailwinds (India's housing cycle, premiumisation, repainting frequency increase with rising incomes) remain intact.
Explore live P/E, ROCE, and valuation data for ASIANPAINT, BERGEPAINT, and KANSAINER at docstox.com.
By the DocStoX Desk — This is for informational purposes only and not investment advice. Please consult a SEBI-registered advisor before investing.
Screen 6,000+ NSE & BSE stocks on these exact metrics, or ask DoXy, our AI analyst. Open the screener · More guides
Informational and educational purposes only, not investment advice. DocStoX is not a SEBI-registered advisor. Consult a SEBI-registered advisor before investing.